Shape Memory Medical Inc.

15 articles about Shape Memory Medical Inc.

• Shape Memory Medical Completes $38 Million in Financing to Advance Endovascular Embolization

  3/4/2024

  Shape Memory Medical Inc., developer of custom shape memory polymers for endovascular markets, announced today that it has completed $38 million in Series C financing.

• Shape Memory Medical Receives FDA IDE Approval to Initiate AAA-SHAPE, a Head-to-Head Trial

  9/7/2023

  Shape Memory Medical Inc announced that the Food and Drug Administration (FDA) granted investigational device exemption (IDE) for the company to begin a prospective, multicenter, randomized, open-label trial to determine safety and effectiveness of the IMPEDE-FX RapidFill® Device to improve abdominal aortic aneurysm (AAA) sac behavior when used with elective endovascular aneurysm repair (EVAR).

• Shape Memory Medical Announces Publication of Study Results in Vascular

  5/30/2023

  Shape Memory Medical Inc., developer of shape memory polymer for peripheral and neurovascular markets, announced the publication of results from the Company’s prospective, open-label, single-arm, safety study of the IMPEDE Embolization Plug in peripheral vascular embolization.

• Shape Memory Medical Completes Enrollment in the AAA-SHAPE Early Feasibility Study

  8/29/2022

  Shape Memory Medical Inc. announced the completion of patient enrollment in AAA-SHAPE, the Company’s prospective, multicenter early feasibility safety study of the IMPEDE-FX RapidFill® Device when used for abdominal aortic aneurysm sac management during elective endovascular aneurysm repair.

• Shape Memory Medical Announces First Patient Enrollment in the AAA-SHAPE Netherlands Study

  8/24/2021

  Shape Memory Medical Inc., developer of innovative therapies for cardiovascular and neurovascular markets, announced the initiation of AAA-SHAPE Netherlands, the Company’s prospective, multicenter early feasibility study of the IMPEDE-FX RapidFill® Device when used for abdominal aortic aneurysm (AAA) sac management during elective endovascular aneurysm repair (EVAR).

• Shape Memory Medical Names Anthony Lipp as Chief Commercial Officer

  4/29/2021

  Shape Memory Medical Inc., developer of innovative products for cardiovascular and neurovascular therapies, is pleased to announce and welcome Anthony Lipp as Chief Commercial Officer.

• Shape Memory Medical Receives CE Mark for IMPEDE-FX RapidFill

  3/10/2021

  Shape Memory Medical Inc., developer of innovative therapies for cardiovascular and neurovascular markets, announced CE Mark Approval for the IMPEDE-FX RapidFill™ Device, an expansion of the IMPEDE family of biodegradable peripheral vascular embolization plugs.

• Shape Memory Medical Names Mary Dennehy as Vice President of Marketing

  9/25/2020

  Shape Memory Medical Inc., developer of innovative therapies for cardiovascular and neurovascular markets, is pleased to announce and welcome Mary Dennehy as Vice President of Marketing.

• Shape Memory Medical Announces First Patient Enrollment in AAA-SHAPE Study

  9/16/2020

  Shape Memory Medical Inc., developer of innovative therapies for cardiovascular and neurovascular markets, announced the initiation of AAA-SHAPE, the Company’s prospective safety study of the IMPEDE-FX Embolization Plug devices when used for abdominal aortic aneurysm (AAA) sac filling during elective endovascular aneurysm repair (EVAR).

• Shape Memory Medical Receives PMDA Approval for the IMPEDE® Embolization Plug Family

  12/2/2019

  Shape Memory Medical Inc. announced that its IMPEDE® Embolization Plugs have been approved in Japan by the Pharmaceuticals and Medical Devices Agency.

• Shape Memory Medical Wins 2019 R&D 100 Award for Its Novel Impede® Embolization Device

  11/4/2019

  Shape Memory Medical is delighted to announce that the IMPEDE® Embolization Plug, a member of its innovative line of vascular embolization products, has won one of the 2019 R&D 100 Awards

• Shape Memory Medical Receives CE Mark for the TrelliX® Embolic Coil System

  10/21/2019

  Shape Memory Medical Inc. announced it has received CE mark for its TrelliX® Embolic Coil System.

• Shape Memory Medical Receives FDA Clearance for the IMPEDE® FX Embolization Plug

  5/28/2019

  Shape Memory Medical Inc. announced it has received 510 clearance from the US Food and Drug Administration for its IMPEDE-FX Embolization Plug.

• Shape Memory Medical Names Bart Balkman as Chief Commercial Officer

  4/2/2019

  Shape Memory Medical Inc. announced that Bart Balkman has joined the Company as its Chief Commercial Officer.

• Shape Memory Medical Raises Series B, Led by HBM Healthcare Investments

  7/25/2017